Objectives The aim of this study to compare the clinic efficacy and effects of osmotic release
oral system-methylphenidate and atomoxetine on executive function in children and …

This study aimed to compare the effects of osmotic release oral system-methylphenidate
(OROS-MPH) and atomoxetine (ATX) on executive function in children and adolescents with …

Objective: The aim of this study was to evaluate and compare the effects of atomoxetine
(ATX) and osmotic release oral system-methylphenidate (OROS-MPH) therapies on …

Objectives: This study aimed to compare the efficacy of methylphenidate and atomoxetine
on improving executive functions among children with attention-deficit/hyperactivity disorder …

The aim of this study was to compare the safety, efficacy, tolerability, and the effects of
atomoxetine and OROS-MPH on executive functions in children with ADHD. This study was …

Aim This study investigated whether components of attention and executive functioning
improve when children with attention‐deficit–hyperactivity disorder (ADHD) are treated with …

We evaluated the effect of osmotic-release oral system (OROS) methylphenidate on learning
skills in adolescents with attention-deficit/hyperactivity disorder (ADHD). In an open-label …

Background Recent guidelines emphasize the importance of functional outcomes in children
with attention-deficit/hyperactivity disorder (ADHD). Here, we assess the functional …

Objective: The efficacy of both methylphenidate and atomoxetine has been established in
placebo-controlled trials. The present study aimed to directly compare the efficacy of …

Background: Attention-deficit hyperactivity disorder (ADHD) is the most common mental and
behavioral disorder in school-aged children. This study evaluated the effect of osmotic …